Jonathan Pearlstein
jonathan.pearlstein.wg12@
wharton.upenn.edu Stanford University, Palo Alto, CA B.A., Honors, Science, Technology, and Society, 2006
Laura E. Peterson
laura.peterson.wg12@
wharton.upenn.edu Duke University, Durham, NC A.B., Public Policy, 2007
John Picasso
john.picasso.wg12@wharton.upenn.edu University of Pennsylvania, Philadelphia, PA B.A., Cum Laude, Biology, 2006; B.S., Cum Laude, Economics, 2006
A strategic or business development opportunity in healthcare services and technology.
The TriZetto Group, Greenwood Village, CO Corporate Strategy Intern, Summer 2011 Defined consumerism strategy for payer-focused health IT company. Evaluated market trends in insurance exchanges, price transparency, and social media. Upward-managed execu- tive team, including Chief Strategy Officer, Chief Medical Officer, and Founder. Primary author of final deliv- erable presented to board of directors.
The Advisory Board Company, Washington, DC Senior Analyst, 2008-2010 Analyst, 2007-2008 Completed 7 best-practice research studies for hospital leaders, including CIOs, Chief HR Officers, and Chief Nursing Officers. For each project, interviewed 80+ top executives at major health systems, analyzed find- ings, and developed final presentation deliverable. Overall, more than 70% of clients rated studies “excellent,” the highest possible score. Example projects include: 1) mitigating nursing workarounds related to clinical IT systems; 2) designing new-hire onboarding toolkit to improve staff retention.
National Opinion Research Center, Washington, DC Research Assistant, 2006-2007 Evaluated performance of $110M portfolio of health IT demonstration projects funded by Agency for Health- care Research and Quality (AHRQ). Employed SAS statistical software to diagnose key challenges and identify longitudinal trends.
An opportunity in pharma/biotech strat- egy analysis or healthcare consulting.
Genentech, South San Francisco, CA New Product Commercialization (NPC) Commercial MBA Intern, Summer 2011 Developed a consolidated roadmap and corresponding guidance document of U.S. commercial activities for organizationally new therapeutic areas, taking into consideration existing U.S. and Global guidance documents and processes, ongoing Roche and Genentech initiatives, and industry best practices.
The Lewin Group, Falls Church, VA Independent Consultant, 2010-2011 Research Consultant, 2010 Senior Research Analyst, 2008-2010 Research Analyst, 2007-2008 Led business development activities related to comparative effectiveness research and genomic data sharing resulting in over $5M in project work and the development of the Lewin Center for Comparative Effectiveness Research. Facilitated government and regulatory affairs panels for major pharmaceutical companies to develop business strategy. Developed a model of the economic impact of a regula- tory pathway for follow-on biologics for the Assistant Secretary for Planning and Evaluation at DHHS that was ultimately adopted by the White House Office of Healthcare Reform. Authored peer-reviewed journal articles, white papers and reports on health technology assessment, pharmaceutical market analysis, evidence-based medicine and comparative effectiveness research.
An opportunity within an entrepreneur- ial team to build and develop innovative healthcare services ventures.
Fifth Street Finance, White Plains, NY Summer Associate, Summer 2011 Created investment memorandums for over 10 middle-market, private equity deals and closed 2 $100M+ transac- tions. Worked with CEO to build Busi- ness Development Center simulation to model fund raising process, invest- ment decisions, initial public offering, follow-on offerings, and capital markets leverage. Worked with Chief Investment Officer and Managing Director to develop firm’s health care investment strategy.
Accenture, New York, NY Manager, Health Care Management Consulting Strategy, 2010 Achieved fastest promotion to Manager from Business Analyst in history of Accenture Strategy practice. Developed integrated, multi-channel go-to-market strategy for portfolio of sixteen pharmaceutical products. Managed implementation of go-to- market strategy across four Accenture workstream teams, marketing vendors, client Brand Leads, and client’s managing project director; successful implementation led to 20-40% increase in sales effectiveness.
Consultant, 2008-2010 Led 4 different project teams to develop strategic recommendations in Analytics, Marketing, Sales, and Managed Markets.
Business Analyst, 2007-2008
22
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40